SAN

82.99

-1.43%↓

MRK1

112.5

-1.53%↓

SHL.DE

46.33

-3.42%↓

ARGX

477.1

-1.28%↓

FRE

41.87

-0.69%↓

SAN

82.99

-1.43%↓

MRK1

112.5

-1.53%↓

SHL.DE

46.33

-3.42%↓

ARGX

477.1

-1.28%↓

FRE

41.87

-0.69%↓

SAN

82.99

-1.43%↓

MRK1

112.5

-1.53%↓

SHL.DE

46.33

-3.42%↓

ARGX

477.1

-1.28%↓

FRE

41.87

-0.69%↓

SAN

82.99

-1.43%↓

MRK1

112.5

-1.53%↓

SHL.DE

46.33

-3.42%↓

ARGX

477.1

-1.28%↓

FRE

41.87

-0.69%↓

SAN

82.99

-1.43%↓

MRK1

112.5

-1.53%↓

SHL.DE

46.33

-3.42%↓

ARGX

477.1

-1.28%↓

FRE

41.87

-0.69%↓

Search

RHOEN-KLINIKUM AG

Uždarymo kaina

10.7 -4.46

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

10.7

Max

11.2

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-6.9M

7.1M

Pardavimai

-9.8M

415M

P/E

Sektoriaus vid.

20

39.564

Pelnas, tenkantis vienai akcijai

0.107

Dividendų pajamingumas

0.84

Pelno marža

1.72

Darbuotojai

18,819

EBITDA

-14M

25M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+9.24% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.84%

2.40%

Kitas uždarbis

2025-08-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-127M

803M

Ankstesnė atidarymo kaina

15.16

Ankstesnė uždarymo kaina

10.7

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

RHOEN-KLINIKUM AG Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-11 22:19; UTC

Įsigijimai, susijungimai, perėmimai

FCC Approves U.S. Cellular Sale to T-Mobile

2025-07-11 17:28; UTC

Pagrindinės rinkos jėgos

SharpLink Gaming Gains on Ethereum Purchase

2025-07-11 16:57; UTC

Uždarbis

BASF Cuts Outlook on Global Economy Uncertainty

2025-07-11 21:45; UTC

Rinkos pokalbiai

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

2025-07-11 19:46; UTC

Įsigijimai, susijungimai, perėmimai

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

2025-07-11 19:45; UTC

Rinkos pokalbiai

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

2025-07-11 19:05; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

2025-07-11 18:18; UTC

Rinkos pokalbiai

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

2025-07-11 17:35; UTC

Rinkos pokalbiai

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

2025-07-11 17:26; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

2025-07-11 16:53; UTC

Rinkos pokalbiai

Crude Futures Add to Early Gains -- Market Talk

2025-07-11 16:42; UTC

Uždarbis

BASF Cuts Outlook on Global Economic Uncertainty

2025-07-11 16:08; UTC

Rinkos pokalbiai

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

2025-07-11 16:05; UTC

Uždarbis

BASF Will Publish Half-Year Results on July 30

2025-07-11 16:04; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-11 16:04; UTC

Rinkos pokalbiai

Senior Housing Shortage Gives REITs Pricing Power -- Market Talk

2025-07-11 16:03; UTC

Uždarbis

BASF: Guidance Cut Is Due to Ongoing Macroeconomic, Geopolitical Uncertainties

2025-07-11 16:02; UTC

Uždarbis

BASF Continues to Expect Free Cash Flow Between EUR400M and EUR800M in 2025

2025-07-11 16:01; UTC

Uždarbis

BASF Had Seen Ebitda Before Special Items Between EUR8B and EUR8.4B in 2025

2025-07-11 16:00; UTC

Uždarbis

BASF Now Sees Ebitda Before Special Items Between EUR7.3B and EUR7.7B in 2025

2025-07-11 15:59; UTC

Uždarbis

BASF Cuts 2025 Earnings View

2025-07-11 15:58; UTC

Uždarbis

Nvidia's CEO Has Sold a Million Shares. He Has Millions More to Sell. -- Barrons.com

2025-07-11 15:57; UTC

Uždarbis

BASF 2Q EBIT Before Special Items EUR810M

2025-07-11 15:54; UTC

Uždarbis

BASF: Analysts Had Expected 2Q Sales of EUR15.80B

2025-07-11 15:54; UTC

Uždarbis

BASF 2Q Sales Fell 2.1% on Year

2025-07-11 15:53; UTC

Uždarbis

BASF 2Q Sales EUR15.77B

2025-07-11 15:52; UTC

Uždarbis

BASF: This Was in Line With Consensus Estimates

2025-07-11 15:52; UTC

Uždarbis

BASF 2Q Ebitda Before Special Items EUR1.77B

2025-07-11 15:49; UTC

Uždarbis

BASF Reports Preliminary 2Q Figures, Adjusts 2025 Outlook

2025-07-11 15:41; UTC

Rinkos pokalbiai

Oil, Gas Prices Not Seen Supporting Drilling Boom -- Market Talk

Akcijų palyginimas

Kainos pokytis

RHOEN-KLINIKUM AG Prognozė

Kainos tikslas

By TipRanks

9.24% į viršų

12 mėnesių prognozė

Vidutinis 13 EUR  9.24%

Aukščiausias 13 EUR

Žemiausias 13 EUR

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines RHOEN-KLINIKUM AG kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

1 ratings

0

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

N/A / 15.2Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

Neutral Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę RHOEN-KLINIKUM AG

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. It also operates acute hospitals, medical care centers, and rehabilitation hospitals. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.